Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, April 7, 2015, 43 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $107.54 to $3,085,320.00.

Highlighted Stocks Traded by Insiders:

Citizens and Northern (CZNC) - FREE Research Report

Fisher Jan E, who is Director at Citizens and Northern, bought 303 shares at $20.51 on April 7, 2015. Following this transaction, the Director owned 15,227 shares meaning that the stake was boosted by 2.03% with the 303-share transaction.

The shares most recently traded at $20.75, up $0.24, or 1.17% since the insider transaction. Historical insider transactions for Citizens and Northern go as follows:

  • 4-Week # shares bought: 1,400
  • 4-Week # shares sold: 650
  • 12-Week # shares bought: 1,447
  • 12-Week # shares sold: 650
  • 24-Week # shares bought: 2,177
  • 24-Week # shares sold: 2,150

The average volume for Citizens and Northern has been 23,800 shares per day over the past 30 days. Citizens and Northern has a market cap of $252.3 million and is part of the financial sector and banking industry. Shares are down 0.48% year-to-date as of the close of trading on Tuesday.

Citizens & Northern Corporation operates as the bank holding company for Citizens & Northern Bank that provides a range of banking and mortgage services to individual and corporate customers in North Central Pennsylvania and Southern New York. The stock currently has a dividend yield of 5.06%. The company has a P/E ratio of 14.9. Currently, there are no analysts who rate Citizens and Northern a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CZNC - FREE

TheStreet Quant Ratings rates Citizens and Northern as a buy. The company's strengths can be seen in multiple areas, such as its expanding profit margins, good cash flow from operations, increase in net income, growth in earnings per share and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Citizens and Northern Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Synchronoss Technologies (SNCR) - FREE Research Report

Doran Patrick Joseph, who is EVP & Chief Technology Office at Synchronoss Technologies, sold 131 shares at $47.17 on April 7, 2015. Following this transaction, the EVP & Chief Technology Office owned 26,603 shares meaning that the stake was reduced by 0.49% with the 131-share transaction.

The shares most recently traded at $47.86, up $0.69, or 1.44% since the insider transaction. Historical insider transactions for Synchronoss Technologies go as follows:

  • 4-Week # shares sold: 2,137
  • 12-Week # shares sold: 222,805
  • 24-Week # shares sold: 655,692

The average volume for Synchronoss Technologies has been 546,800 shares per day over the past 30 days. Synchronoss Technologies has a market cap of $2.0 billion and is part of the technology sector and computer software & services industry. Shares are up 13.93% year-to-date as of the close of trading on Tuesday.

Synchronoss Technologies, Inc. provides cloud solutions and software-based activation for connected devices worldwide. The company has a P/E ratio of 50.9. Currently, there are 7 analysts who rate Synchronoss Technologies a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on SNCR - FREE

TheStreet Quant Ratings rates Synchronoss Technologies as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Synchronoss Technologies Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

MKS Instruments (MKSI) - FREE Research Report

Hanley Peter, who is Director at MKS Instruments, sold 325 shares at $33.34 on April 7, 2015. Following this transaction, the Director owned 4,524 shares meaning that the stake was reduced by 6.7% with the 325-share transaction.

The shares most recently traded at $33.62, up $0.28, or 0.83% since the insider transaction. Historical insider transactions for MKS Instruments go as follows:

  • 4-Week # shares bought: 1,161
  • 4-Week # shares sold: 2,000
  • 12-Week # shares bought: 1,161
  • 12-Week # shares sold: 11,771
  • 24-Week # shares bought: 1,161
  • 24-Week # shares sold: 32,136

The average volume for MKS Instruments has been 215,300 shares per day over the past 30 days. MKS Instruments has a market cap of $1.8 billion and is part of the technology sector and electronics industry. Shares are down 7.62% year-to-date as of the close of trading on Tuesday.

MKS Instruments, Inc. provides instruments, subsystems, and process control solutions that measure, control, power, monitor, and analyze critical parameters of manufacturing processes in the United States and internationally. The stock currently has a dividend yield of 1.95%. The company has a P/E ratio of 15.7. Currently, there are 3 analysts who rate MKS Instruments a buy, 1 analyst rates it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MKSI - FREE

TheStreet Quant Ratings rates MKS Instruments as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full MKS Instruments Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null